Press Releases

City of Hope leads first U.S. clinical trial testing efficacy of delivering chemotherapy into the abdomen via a fine spray

August 11, 2020

The experimental PIPAC treatment may extend the lives of people with advanced ovarian, uterine, gastric and colorectal cancers whose current options are only local disease control and palliative care.

City of Hope’s Music, Film & Entertainment Industry group to launch high-end virtual auction series offering remarkable music memorabilia and unique experiences

August 3, 2020

City of Hope announced today that it will launch a high-end weekly virtual auction series in partnership with Charitybuzz.

City of Hope scientists leverage interference between signaling pathways for cancer treatment

July 22, 2020

Based on that research, new drug combinations aim to intercept cancer development.

City of Hope, TGen looking to create personalized roadmaps for the treatment of kidney cancer

July 22, 2020

Physician-scientists are using one of the world’s most comprehensive genomic analysis tools to determine whether targeted therapy or immunotherapy has the best chance of working for each individual patient.

City of Hope researchers identify mechanism that may lead to metabolic memory and sustained diabetes complications

July 20, 2020

New data show how early episodes of hyperglycemia can have long-term effects.

Study led by City of Hope, TGen shows new way of identifying tumor response to immunotherapy

June 22, 2020

Findings could improve personalized medicine for cancer patients.

Two new, powerful small molecules may be able to kill cancers that other therapies can’t

June 16, 2020

City of Hope scientists demonstrate that the cancer inhibitors they’re developing could destroy acute myeloid leukemia and tumors from brain, pancreatic and breast cancers.

Glenn D. Steele, Jr., M.D., Ph.D., renowned health care leader and innovator, named chair of City of Hope Board of Directors

June 15, 2020

Steele, former president/chief executive officer of Geisinger Health System, will lead the center’s board of directors.

City of Hope signs licensing agreement with Scopus BioPharma Inc. to develop novel, targeted immuno-oncology gene therapy

June 11, 2020

A phase 1 clinical trial using the STAT 3 inhibitor is expected to commence at City of Hope later this year.

City of Hope scientists showcase new findings at the 2020 AACR Virtual Annual Meeting II

June 9, 2020

These important proof-of-concept studies could one day lead to new real-time diagnostic imaging techniques and the identification of genomic biomarkers that predict treatment results – innovations that will improve health outcomes for cancer patients